A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Public ClinicalTrials.gov record NCT06809400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Study identification
- NCT ID
- NCT06809400
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Interventions
- LY4006896 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 17, 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
- Last update posted
- Apr 19, 2026
2025 – 2028
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Network - CNS | Los Alamitos | California | 90720 | Recruiting |
| K2 Medical Research, LLC | Maitland | Florida | 32751 | Completed |
| Aqualane Clinical Research | Naples | Florida | 34105 | Recruiting |
| Charter Research | Orlando | Florida | 32803 | Recruiting |
| Progressive Medical Research | Port Orange | Florida | 32127 | Recruiting |
| K2 Medical Research, LLC | The Villages | Florida | 32159 | Recruiting |
| Charter Research | The Villages | Florida | 32162-2698 | Recruiting |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | Recruiting |
| PPD Development, LP | Austin | Texas | 78744 | Recruiting |
| Evergreen Health Research | Kirkland | Washington | 98034 | Not yet recruiting |
| Inland Northwest Research | Spokane | Washington | 99202 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06809400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06809400 live on ClinicalTrials.gov.